U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182279) titled 'Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer' on Aug. 01.
Brief Summary: This is a Phase I/II trial evaluating the effectiveness of adding neoadjuvant HDR-B prior to RALP for HR-PCa patients with selective AAB for decipher high risk or pathologically node positive patients.
Patients with newly diagnosed, histologically confirmed, non-metastatic, HR-PCa who are scheduled to receive RALP will be eligible to participate in the study.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer (Adenocarcinoma)
Intervention:
DRUG: Brachytherapy
All p...